Vivos (RDGL) Net Cash Flow Growth (5y) (2015 - 2025)
Vivos (RDGL) Net Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.13% |
| Sep 30, 2025 | -14.41% |
| Jun 30, 2025 | -34.97% |
| Mar 31, 2025 | 134.19% |
| Dec 31, 2024 | 55.86% |
| Sep 30, 2024 | -39.98% |
| Jun 30, 2024 | 66.05% |
| Mar 31, 2024 | -51.95% |
| Dec 31, 2023 | 58.78% |
| Jun 30, 2023 | -622.20% |
| Mar 31, 2023 | -104.05% |
| Dec 31, 2022 | -82.82% |
| Sep 30, 2022 | 4.02% |
| Jun 30, 2022 | -20.06% |
| Mar 31, 2022 | -146.89% |
| Dec 31, 2021 | 34.94% |
| Sep 30, 2021 | -15.48% |
| Jun 30, 2021 | -6.98% |
| Mar 31, 2021 | 87.77% |
| Dec 31, 2020 | 38.94% |